Centers for Disease Control and Prevention. HIV, surveillance report. 2021. 2023;34. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV Transmission in an urban setting: an outbreak of HIV infection among people who inject Drugs—Massachusetts, 2015–2018. Am J Public Health. 2020;110(1):37–44.
Article PubMed PubMed Central Google Scholar
Bureau of Infectious Disease and Laboratory Sciences. Massachusetts HIV Epidemiologic Profile, Statewide Report – Data as of 1/1/2022 [Internet]. Boston: Massachusetts Department of Public Health. 2022 Feb [cited 2023 Oct 5]. https://www.mass.gov/lists/hivaids-epidemiologic-profiles
Harris MT, Goldenberg S, Cui Z, Fairbairn N, Milloy MJS, Hayashi K, et al. Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada. Int J Drug Policy. 2023;112:103950.
Article PubMed PubMed Central Google Scholar
Burnette ML, Lucas E, Ilgen M, Frayne SM, Mayo J, Weitlauf JC. Prevalence and Health correlates of Prostitution among patients entering treatment for Substance Use disorders. Arch Gen Psychiatry. 2008;65(3):337–44.
Goldenberg S, Liyanage R, Braschel M, Shannon K. Structural barriers to condom access in a community-based cohort of sex workers in Vancouver, Canada: influence of policing, violence and end-demand criminalisation. BMJ Sex Reprod Health. 2020;46(4):301–7.
Article PubMed PubMed Central Google Scholar
Sherman SG, Park JN, Galai N, Allen ST, Huettner SS, Silberzahn BE, et al. Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore city: results from the SAPPHIRE study. JAIDS J Acquir Immune Defic Syndr. 2019;80(5):513–21.
Footer KHA, Park JN, Allen ST, Decker MR, Silberzahn BE, Huettner S, et al. Police-related correlates of client-perpetrated violence among female sex workers in Baltimore City, Maryland. Am J Public Health. 2019;109(2):289–95.
Article PubMed PubMed Central Google Scholar
Decker MR, Park JN, Allen ST, Silberzahn B, Footer K, Huettner S, et al. Inconsistent condom Use among Female Sex workers: Partner-specific influences of Substance Use, Violence, and Condom Coercion. AIDS Behav. 2020;24(3):762–74.
Article PubMed PubMed Central Google Scholar
Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. US Public Health Service. 2018.
US Preventive Services Task Force. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;330(8):736–45.
Aaron E, Cohan D. Preexposure prophylaxis for the prevention of HIV transmission to women. AIDS. 2013;27(1):F1–5.
Earlywine JJ, Bazzi AR, Biello KB, Klevens RM. High Prevalence of Indications for Pre-exposure Prophylaxis Among People Who Inject Drugs in Boston, Massachusetts. American Journal of Preventive Medicine [Internet]. 2020 Nov 21 [cited 2021 Jan 20]; http://www.sciencedirect.com/science/article/pii/S0749379720304451
Footer KHA, Lim S, Rael CT, Greene GJ, Carballa-Diéguez A, Giguere R, et al. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city. AIDS Care. 2019;31(10):1207–13.
Article PubMed PubMed Central Google Scholar
Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, et al. The PrEP Care Continuum among Cisgender Women who sell sex and/or use drugs globally: a systematic review. AIDS Behav. 2020;24(5):1312–33.
Article PubMed PubMed Central Google Scholar
Walters SM, Platt J, Anakaraonye A, Golub SA, Cunningham CO, Norton BL, et al. Considerations for the design of pre-exposure Prophylaxis (PrEP) interventions for women: lessons learned from the implementation of a Novel PrEP intervention. AIDS Behav. 2021;25(12):3987–99.
Article PubMed PubMed Central Google Scholar
Felsher M, Ziegler E, Smith LR, Sherman SG, Amico KR, Fox R, et al. An exploration of pre-exposure Prophylaxis (PrEP) initiation among women who inject drugs. Arch Sex Behav. 2020;49(6):2205–12.
Article PubMed PubMed Central Google Scholar
Taylor JL, Laks J, Christine PJ, Kehoe J, Evans J, Kim TW, et al. Bridge clinic implementation of 72-hour rule methadone for opioid withdrawal management: impact on opioid treatment program linkage and retention in care. Drug Alcohol Depend. 2022;236:109497.
Article CAS PubMed Google Scholar
Roy PJ, Choi S, Bernstein E, Walley AY. Appointment wait-times and arrival for patients at a low-barrier access addiction clinic. J Subst Abuse Treat. 2020;114:108011.
Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: a qualitative study of a bridge clinic. J Subst Abuse Treat. 2019;107:1–7.
Taylor JL, Wakeman SE, Walley AY, Kehoe LG. Substance use disorder bridge clinics: models, evidence, and future directions. Addict Sci Clin Pract. 2023;18(1):23.
Article PubMed PubMed Central Google Scholar
Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, et al. Sexually transmitted and blood-borne infections among patients presenting to a low-barrier Substance Use Disorder Medication Clinic. J Addict Med. 2021;15(6):461–7.
Article PubMed PubMed Central Google Scholar
Braun HM, Walter C, Farrell N, Biello KB, Taylor JL. HIV exposure Prophylaxis Delivery in a low-barrier Substance Use Disorder Bridge clinic during a local HIV outbreak at the onset of the COVID-19 pandemic. J Addict Med. 2022;16(6):678–83.
Article PubMed PubMed Central Google Scholar
Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Substance Abuse. 2019;40(4):441–3.
Madoff L, Brown C, Lo JJ, Sánchez S. Public Health Alert to Boston Area Healthcare Providers: increase in newly diagnosed HIV infections among persons who inject drugs in Boston. Massachusetts Department of Public Health Boston Public Health Commission; 2021.
Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 Update: A Clinical Practice Guideline. US Public Health Service [Internet]. 2021 [cited 2023 Mar 29]; https://www.cdc.gov/hiv/effective-interventions/prevent/prep/index.html
Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31(5):731–4.
Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure Prophylaxis (PrEP) Care Cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490–506.
Strathdee SA, West BS, Reed E, Moazen B, Moazan B, Azim T, et al. Substance Use and HIV among female sex workers and female prisoners: risk environments and implications for Prevention, Treatment, and policies. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S110–117.
Article PubMed PubMed Central Google Scholar
Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.
Article PubMed PubMed Central Google Scholar
Bekker LG, Johnson L, Cowan F, Overs C, Besada D, Hillier S, et al. Combination HIV prevention for female sex workers: what is the evidence? Lancet. 2015;385(9962):72–87.
Chang SJ, Choi S, Kim SA, Song M. Intervention strategies based on Information-Motivation-Behavioral Skills Model for Health Behavior Change: a systematic review. Asian Nurs Res. 2014;8(3):172–81.
Burla L, Knierim B, Barth J, Liewald K, Duetz M, Abel T. From text to codings: Intercoder Reliability Assessment in qualitative content analysis. Nurs Res. 2008;57(2):113–7.
Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Sage; 2014.
Miles MB, Huberman AM, Saldaña J. Qualitative data analysis: a methods sourcebook. Sage; 2018.
Food and Drug Adminstration, New Release FDA. FDA; 2021 [cited 2022 Jan 11]. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;29(1):40.
Wilson EC, Jin H, Liu A, Raymond HF. Knowledge, indications and willingness to take Pre-exposure Prophylaxis among Transwomen in San Francisco, 2013. PLoS ONE. 2015;10(6):e0128971.
留言 (0)